Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
Clinical Assessment of 31 Patients with Wilson's Disease, Correlations with Struct. Changes on MRI
Arch Neurol 44:365-370, Starosta-Rubinstein,S.,et al, 1987
Clinicopathologic Conference, Cotards Syndrome, Catatonia, Depression and Coronavirus Disease 2019
NEJM 387:1795-1802, , 2022
Prodromal Symptoms of Multiple Sclerosis in Primary Care
Ann Neurol 83:1162-1173, Disanto,G.,et al, 2018
High Hypothetical Interest in Physician-Assisted Death in Multiple Sclerosis
Neurol 88:1528-1534, Marrie, R.A.,et al, 2017
Migraine
NEJM 377:553-561, Charles, A., 2017
Depressive Symptoms and Risk of Stroke: The Framingham Study
Stroke 38:16-21, Salaycik,K.J.,et al, 2007
Neuropsychiatric Syndromes Associated With Multiple Sclerosis
J Neurol 254:II/73-II/76, Feinstein,A., 2007
Obsessive-Compulsive Disorder
BMJ 333:424-429, Heyman,I.,et al, 2006
Central Nervous System Injury Associated with Cardiac Surgery
Lancet 368:694-703, Newman,M.F.,et al, 2006
The Outcome of Neurology Outpatients with Medically Unexplained Symptoms: A Prospective Cohort Study
JNNP 74:897-900,842, Carson,A.J.,et al, 2003
Cognitive Presentation of Multiple Sclerosis: Evidence for a Cortical Variant
JNNP 74:872-877, Zarei,M.,et al, 2003
What Contributes to Quality of Life in Patients with Parkinson's Disease?
JNNP 69:308-312,289, Schrag,A. et al, 2000
Depressive Symptoms and Increased Risk of Stroke Mortality Over a 29-Year Period
Arch Int Med 158:1133-1138, Everson,S.A.,et al, 1998
A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997
Clinical Characteristics of Patients with Motor Disability Due to Conversion Disorder:A Prospective Study
JNNP 63:83-88, Binzer,M.,et al, 1997
Multiple Sclerosis, Depression, and Suicide
BMJ 315:691-692, Feinstein,A., 1997
Diagnosis and Treatment of Alzheimer Disease and Related Disorders
JAMA 278:1363-1371, Small,G.W.,et al, 1997
A New Variant of Creutzfeldt-Jakob Disease in the UK
Lancet 347:921-925, 915, 916, 91796., Will,R.G.,et al, 1996
Chronic Spinal Cord Injury
NEJM 330:550-556, Ditunno,J.F.&Formal,C.S., 1994
Effects of Vigabatrin on Partial Seizures and Cognitive Function
JNNP 57:1057-1063, Grunewald,R.A.,et al, 1994
Risk Factors for Parkinson's Disease
Neurol 43:1693-1697, 16411993., Hubble,J.P.,et al, 1993
Nervous System Lyme Borreliosis-Revisited
Arch Neurol 49:102-107, Finkel,M.J.&Halperin,J.J., 1992
The Impact of Poststroke Depression on Recovery in ADL Over a 2-year Follow-up
Arch Neurol 47:785-789, Parikh,R.M.,et al, 1990
The Spectrum of Depression in Multiple Sclerosis, An Approach for Clinical Management
Arch Neurol 44:596-599, Schiffer,R.B., 1987
Risk Factors for Alzheimer's Disease:A Case-Control Study
Neurol 37:1630-1633, Shalat,S.T.,et al, 1987
Depression as a Major Symptom of Multiple Sclerosis
JNNP 43:861-865, Whitlock,F.A.,et al, 1980
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Organic Disease Presenting as a Psychiatric Syndrome
Postgrad Med 54:78, , 1973
Neurologic Signs & Symptoms as Early Manifestations of SLE
Neurol 5:84, Siekert,R.,et al, 1955
Clinicopathologic Conference, Poststroke Mania and the Frontal Lobe Syndrome
NEJM 379:182-189, Case 21-2018, 2018
Assessment and Management of Behavioral and Psychological Symptoms of Dementia
BMJ 350:h369, Kales, H.C.,et al, 2015
Deep-Brain Stimulation - Entering the Era of Human Neural-Network Modulation
NEJM 371:1369-1373, Okun, M.S., 2014
A Randomized, Double-Blind, Placebo-Controlled Trial of Antidepressants in Parkinson Disease
Neurol 78:1229-1236, Richard,I.H.,et al, 2012
Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK
JNNP 82:646-651, Heath, C.A.,et al, 2011
Suicide-Related Events in Patients Treated With Antiepileptic Drugs
NEJM 363:542-551, Arana,A., et al, 2010
Polymyalgia Rheumatica
BMJ 336:765-769, Michet,C.J. &Matteson,E.L., 2008
Management of Depression After Stroke
Stroke 36:1092-1097, Hackett,M.L.,et al, 2005
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Pract Neurology 4:50-55, Razvi,S.S.M. &Muir,K.W., 2004
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Effect on Mood of Subthalamic DBS for Parkinson's Disease
Neurol 59:1427-1429, Berney,A.,et al, 2002
Medical Complications After Stroke
Stroke 31:1223-1229, Langhorne,P.,et al, 2000
Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000
Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation
NEJM 340:1476-1480,1500, Bejjani,B-P.,et al, 1999
Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation
NEJM 341:1003-1004, Bezerra,M.L.S.,et al, 1999
Psychiatric Adverse Events During Vigabatrin Therapy
Neurol 53:1503-1511, Levinson,D.F.&Devinsky,O., 1999
Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998
A Survey of Antidepressant Drug Use in Parkinson's Disease
Neurol 49:1168-1170, Richard,I.H.,et al, 1997
Generalized Anxiety Disorder in Stroke Patients
Stroke 27:270-275, Astrom,M., 1996